TrialReader


Genomic Assessment of Patients With Severe Radiation Reactions

NCT03287349 — Completed, 3 participants, Mayo Clinic

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03287349
StatusCompleted
Study typeObservational
Enrollment3 (Actual)
SponsorMayo Clinic (Other)
ConditionsRadiation; Reaction
InterventionsBlood draw, Photograph, Autoimmune testing (Other, diagnostic test)
Datesstart 2017-05-10, primary completion 2023-01-04, completion 2023-01-04, first posted 2017-09-19, last updated 2024-11-15
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Radiation; Reaction All trials of Blood draw All trials of Photograph

-Summary

Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Patients with severe reactions to radiationOther: Blood draw; Other: Photograph; Diagnostic Test: Autoimmune testingTwo 12.5 mL blood draws and photograph of severe reaction, and autoimmune testing in patients without prior testing.
  • Blood draw (Other): Two 12.5 mL blood draws
  • Photograph (Other): Photograph of severe reaction, will be anonymized
  • Autoimmune testing (Diagnostic test): Autoimmune testing in patients without prior testing

+Outcome measures

Primary outcomes

  • Whole exome sequencing [baseline]: Investigate genes potentially responsible for severe radiation reactions by getting blood draws.

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Weigh at least 110 pounds
* Healthy

Exclusion Criteria:

\- Pregnant

+Locations (1)

FacilityCityCountryStatus
Mayo Clinic in RochesterRochester, MinnesotaUnited States

+Investigators

My Notes